Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CDN Isotopes is a premier manufacturer and supplier of deuterium-labeled compounds used extensively in scientific research and analytical testing. Based in Quebec, Canada, the company maintains a vast inventory of over 3,400 stable isotope-labeled chemicals, including amino acids, steroids, pesticides, and pharmaceutical actives. These products are critical components for applications in nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry, and metabolic studies. In 2020, the company was acquired by LGC Standards, a move that integrated its specialized synthesis capabilities into a global portfolio of reference materials. CDN Isotopes serves a diverse international clientele across the pharmaceutical, environmental, and academic sectors. The company is recognized for its high-purity standards and expertise in complex isotopic labeling.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CDN Isotopes.